about
The role of cullin 5-containing ubiquitin ligasesImpact of temperature dependent sampling procedures in proteomics and peptidomics--a characterization of the liver and pancreas post mortem degradomeC-peptide microheterogeneity in type 2 diabetes populations.The role of insulin C-peptide in the coevolution analyses of the insulin signaling pathway: a hint for its functions.Basal C-peptide Level as a Surrogate Marker of Subclinical Atherosclerosis in Type 2 Diabetic Patients.C-peptide has no effect on forearm blood flow during local hyperinsulinaemia in healthy humans.Factors associated with diabetic retinopathy in chinese patients with type 2 diabetes mellitus.Total chemical synthesis of human proinsulin.Proinsulin C-peptide elicits disaggregation of insulin resulting in enhanced physiological insulin effects.C-peptide is independent associated with diabetic peripheral neuropathy: a community-based study.C-peptide: a new mediator of atherosclerosis in diabetesC-Peptide and its career from innocent bystander to active player in diabetic atherogenesis.Ligand-independent activation of peroxisome proliferator-activated receptor-gamma by insulin and C-peptide in kidney proximal tubular cells: dependent on phosphatidylinositol 3-kinase activity.C-Peptide in insulin resistance and vascular complications: teaching an old dog new tricks.Association between serum C-peptide levels and chronic microvascular complications in Korean type 2 diabetic patients.C-peptide improves adenosine-induced myocardial vasodilation in type 1 diabetes patients.Unraveling the aggregation propensity of human insulin C-peptide.
P2860
Q26749274-EAB7D68F-2FEC-4B74-98C1-D7E5C5D58E4DQ28386567-83B711A7-29DF-4A45-A8FE-DF5FDDFC0117Q33764455-1E816B6E-B11F-45F6-A405-9F81CAA70941Q34541299-7EBB7B8B-667B-49D6-8A1C-6FBEAED8AE55Q34829079-52F83E24-7454-4846-B43F-ED3703B30236Q35825308-0FE39D4C-7658-47B7-9D83-E6485BB0C285Q36104391-9FD6ECC5-1D15-4648-9B49-753A289A17C1Q37329856-AAB3BF58-100A-49BC-A770-9581B97BB786Q37413199-F658FB50-CF47-4581-8E85-EB1C6E1EE640Q37640703-A06F8C10-BFF7-4871-B417-45728BFE608EQ38006686-E6040432-14B1-4758-BD84-44C0B9A28EA5Q38112357-17F3DB74-3FB6-481C-AFD6-52C694870F15Q42467751-4FA601E1-48BA-45D9-A1C8-368F2F826565Q42912257-16F261BA-FEAF-4119-ACE2-A8F3D058445DQ43713192-B2D89D0E-0E03-42C8-B0B5-DBB0672F7869Q44572740-2FD85602-C481-49DD-878D-C16121C1BD37Q46600113-5FAE42A9-ADFF-474F-9BFB-0C298E72EF0B
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Molecular effects of proinsulin C-peptide.
@ast
Molecular effects of proinsulin C-peptide.
@en
Molecular effects of proinsulin C-peptide.
@nl
type
label
Molecular effects of proinsulin C-peptide.
@ast
Molecular effects of proinsulin C-peptide.
@en
Molecular effects of proinsulin C-peptide.
@nl
prefLabel
Molecular effects of proinsulin C-peptide.
@ast
Molecular effects of proinsulin C-peptide.
@en
Molecular effects of proinsulin C-peptide.
@nl
P2093
P50
P1476
Molecular effects of proinsulin C-peptide.
@en
P2093
Hans Jörnvall
Jawed Shafqat
Karin Ekberg
Mikael Henriksson
P304
P356
10.1016/S0006-291X(02)00721-0
P407
P577
2002-08-01T00:00:00Z